الكشف عن بكتيريا Staphylococcus aureus وبكتيريا Pseudomonas aeruginosa لدى مرضى قرحة القدم السكري في محافظة واسط

Abalkhail, A., & Elbehiry, A. (2023). Virulence determinants and antimicrobial resistance patterns of Staphylococcus aureus isolated from diabetic foot infections. Microbial Pathogenesis, 178, 106098.

Afonso, A. C., Oliveira, D., Saavedra, M. J., Borges, A., & Simões, M. (2021). Biofilms in diabetic foot ulcers: Impact, risk factors and control strategies. International Journal of Molecular Sciences, 22(15), 8278.

Alkhatieb, M. T., et al. (2024). Common pathogens associated with infected diabetic foot ulcers. Journal of Family Medicine and Primary Care, 13(7), 2758–2763.

Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2023). Diabetic foot ulcers and their recurrence. The Lancet, 401(10378), 1386–1398.

Barrigah-Benissan, K., Mensah, E., & Koumavi, K. (2023). Biofilm formation and antimicrobial resistance in Pseudomonas aeruginosa isolated from chronic diabetic wounds. Frontiers in Cellular and Infection Microbiology, 13, 1187456. https://doi.org/10.3389/fcimb.2023.1187456

Becker, K., Schaumburg, F., & Kock, R. (2023). Staphylococcus aureus: Molecular evolution and clinical implications. Clinical Microbiology Reviews, 36(2), e00123-22.

Burgess, J. K., McCafferty, D. M., & Smith, C. J. (2021). Hyperglycemia-induced ROS and wound healing impairment. Redox Biology, 41, 101917. https://doi.org/10.1016/j.redox.2021.101917

Chieffi, D., et al. (2024). A novel approach based on real-time PCR with high-resolution melting analysis for Staphylococcus aureus identification. Foods, 13(18), 3004. https://doi.org/10.3390/foods13183004

Darwitz, B. P., et al. (2025). Pseudomonas aeruginosa differentially influences antibiotic tolerance in diabetic wound pathogens. mBio.

Dawi, J., et al. (2025). Diabetic foot ulcers: Pathophysiology, immune dysregulation and therapeutic approaches. Pharmaceutics, 17(6), 728. https://doi.org/10.3390/pharmaceutics17060728

Garousi, M., et al. (2023). Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: A global systematic review and meta-analysis. Germs, 13(4), 362–372.

Garousi, M., Mehravaran, H., Rad, M. R., Abdollahi, A., & Shahcheraghi, F. (2023). Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: A systematic review and meta-analysis. Microbiology Research, 13(4), 996–1012. https://doi.org/10.3390/microbiolres13040068

Gawad, M. A., & Gharbi, W. A. (2022). Molecular detection of oprI and oprL virulence genes of Pseudomonas aeruginosa isolated from burns and wounds. Iraqi Journal of Biotechnology, 21(2).

Gharehaghaji, N., Faraji, R., & Bahar, M. (2021). PCR detection of Pseudomonas aeruginosa in diabetic foot ulcers using oprL gene. Journal of Microbiological Methods, 186, 106627. https://doi.org/10.1016/j.mimet.2021.106627

Goh, C. L., Lim, T. K., & Tan, T. Y. (2020). PCR-based molecular diagnostics in diabetic foot infections. Diagnostics, 10(8), 585. https://doi.org/10.3390/diagnostics10080585

Khodabandeh, F., Farahani, A., & Ghasemi, Y. (2021). PCR-based identification of S. aureus using nuc gene in diabetic foot ulcers. Journal of Clinical Microbiology, 59(12), e02456-21. https://doi.org/10.1128/JCM.02456-21

Kim, C. H., Khan, M., Morin, D. E., Hurley, W. L., Tripathy, D. N., Kehrli, M., Jr., et al. (2001). Optimization of the PCR for detection of Staphylococcus aureus nuc gene in bovine milk. Journal of Dairy Science, 84(1), 74–83.

Lipsky, B. A., Senneville, E., Abbas, Z. G., et al. (2023). Guidelines for the diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases, 76(Suppl. 2), S143–S150. https://doi.org/10.1093/cid/ciad111

Maity, S., et al. (2024). A systematic review of diabetic foot infections. International Journal of Lower Extremity Wounds.

Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2021). Therapeutic strategies targeting Pseudomonas aeruginosa biofilms. Frontiers in Microbiology, 12, 661. https://doi.org/10.3389/fmicb.2021.00661

Nazer, M. A. M. A., et al. (2024). A study on the conventional and molecular approaches for bacterial identification in diabetic foot infections. Biomedical and Biotechnology Research Journal.

Norton, P., et al. (2024). Understanding and treating diabetic foot ulcers: Insights into the role of cutaneous microbiota. Skin Health and Disease, 4(4), e399.

Pang, Z., Raudonis, R., & Glick, B. R. (2022). Pseudomonas aeruginosa virulence factors and chronic wound pathogenesis. Frontiers in Microbiology, 13, 801234. https://doi.org/10.3389/fmicb.2022.801234

Parveen, K., et al. (2025). Comprehensive review on diabetic foot ulcers and neuropathy. PMC Article.

Sahu, A., & Ruhal, R. (2025). Immune system dynamics in response to Pseudomonas aeruginosa biofilms. npj Biofilms and Microbiomes, 11, 104.

Senneville, É., et al. (2023). IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections. Clinical Infectious Diseases.

Senneville, É., Albalawi, Z., van Asten, S. A., et al. (2024). IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections. Diabetes/Metabolism Research and Reviews, 40, e3687.

Tong, S. Y. C., Davis, J. S., & Eichenberger, E. (2023). Staphylococcus aureus infections: Epidemiology, pathophysiology, and management updates. The Lancet, 401(10383), 1236–1250.

Versey, Z., Nizer, W. S. D. C., Russell, E., Zigic, S., DeZeeuw, K. G., Marek, J. E., Overhage, J., & Cassol, E. (2021). Biofilm–innate immune interface: Contribution to chronic wound formation. Frontiers in Immunology, 12, 648554.

Wang, C., Hou, M., & Zhang, J. (2022). Pseudomonas aeruginosa detection using conventional and molecular methods. Frontiers in Microbiology, 13, 820431. https://doi.org/10.3389/fmicb.2022.820431

Wang, X., et al. (2022). Diabetic foot ulcers: Classification, risk factors and management. World Journal of Diabetes, 13(12), 1049–1065.